Anatomical, histochemical and neurochemical investigations have shown the existence of a dense serotonergic innervation in the spinal cord (1, 2) . Many studies have suggested that the serotonergic system originating from the nucleus raphe magnus and extending to the spinal dorsolateral funiculus (3) (4) (5) is involved in the modulation of antinociception in the spinal cord (1, (6) (7) (8) .
Recent reports have suggested that some neuroactive peptides are considered to be putative transmitters in the central nervous system (9) , and they may be the modulators of antinociception (10, 11) . Enkephalincontaining interneurones have been shown in the substantia gelatinosa of the spinal cord (12) . However, the physiological role of neuropeptides in the spinal cord is not clearly known. In a previous in vitro study we already showed the action of neuropeptides on 5-HT release from rat spinal slices (13) . In the present study, we have attempted to investigate the effect of neuroactive peptides on the release of 5-HT from the spinal cord in vivo and have further explored the relationship and possible mechanism of antinociception between neuropeptides and sero- serotonin-containing fibers descending from raphe nuclei are thought to play a role in controlling pain transmission at the spinal level (17) . The present experiment was designed to determine the relationship between 5-HT and neuroactive peptides in the spinal cord in the pain control mechanism. In this experiment, the release of 5-HT from the spinal cord was enhanced by high potassium concentration, and this effect was calcium-dependent.
This result is in agreement with previous results demonstrating a calcium-dependent release of 5-HT from the spinal cord in vitro (15) .
Substance P is widely distributed in the central nervous system and is considered as a neurotransmitter of pain in the primary afferent fibers. This substance has been shown to be a powerful excitant of neurones in the spinal cord and seems to excite selectively dorsal horn cells that respond to noxious stimuli (18) . Met-EK was also suggested to be an inhibitory transmitter in the marginal layer of the trigeminal caudal nucleus and laminae II-IV of the spinal cord (12) . The possibility of a certain interaction between substance P and met-EK was also reported (19) . It was postulated that some opiate receptors were located on the presynaptic nerve terminals containing substance P in the substantia gelatinosa (20) . Recent immunohistochemical findings suggested that en kephali n-containing local interneurones were abundant in the substantia gelatinosa area of the spinal cord (12) . Opiates can act presynaptically to inhibit neurotransmitter release from a variety of other neurones.
In this experiment, 5-HT release evoked by exogenously administered substance P was slightly potentiated by met-EK, although met-EK had shown no effect on 5-HT release when administered alone. This result may suggest that met-EK might act on a presynaptic site of the primary sensory neurones and inhibit the intrinsic substance P release, so that substance P receptors existing in the serotonergic nerve terminal are more susceptible to exogenous substance P.
Noxious cutaneous stimulation by means of pinching produced 5-HT release from the spinal cord. This effect was inhibited by met-EK or baclofen which was reported to be a substance P antagonist in the central nervous system (21) . Furthermore, naloxone, an opiate antagonist, potentiated the 5-HT release induced by tail pinch , although it had no effect on the spontaneous 5-HT release. The effect of naloxone may be due to the inhibition of endogenous opioid peptides which are released from the spinal cord by tail pinch and then act on the presynaptic receptors in the primary sensory afferent neurones. These results suggest that the peripheral pain stimulation-produced 5-HT release may be mediated via an intrinsic substance P release from primary sensory neurones.
It has been shown in an iontophoretic experiment that substance P may play a role in the regulation of the level of excitability of spinal neurones which respond to noxious cutaneous stimuli (22). It was reported that naloxone antagonized the reduction of substance P-like immunoreactivity evoked by opiate at the terminal of nociceptive primary afferent fibers (19, 20) .
With these previous reports, the present study suggests that substance P and met-EK may act on the autoregulation for pain control in the spinal cord.
